Cargando…
Comparison of international guidelines for early-phase clinical trials of cellular and gene therapy products
Cellular and gene therapies (CGT) are promising fields that are bringing significant clinical benefits to patients by directly targeting the underlying cause of disease. In line with this trend, regulatory agencies in every country have been making efforts to accelerate CGT product development. For...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979759/ https://www.ncbi.nlm.nih.gov/pubmed/35419313 http://dx.doi.org/10.12793/tcp.2022.30.e2 |